Daslemia 50mg Tablet

About

Daslemia 50mg Tablet contains the active ingredient Dasatinib. It is prescribed for adults and children over one year of age to treat Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive (Ph+) Acute Lymphoblastic Leukemia (ALL) in patients resistant to other treatments. It is also used for newly diagnosed Ph+ CML in the chronic phase.

Chronic Myeloid Leukemia is a blood cancer caused by an abnormal Philadelphia chromosome, leading to the overproduction of white blood cells. Acute Lymphoblastic Leukemia, more common in children, occurs when lymphocytes multiply too quickly and survive longer than normal.

Common side effects of Daslemia 50mg Tablet include diarrhea, headache, cough, rash, nausea, tiredness, vomiting, muscle pain, weakness, loss of appetite, and changes in blood pressure. Inform your doctor if these effects persist or cause discomfort.

Do not take Daslemia if you are allergic to Dasatinib or any of its ingredients. Before starting treatment, inform your doctor if you have liver or heart problems, breathing difficulties, chest pain, cough, hepatitis B infection, or bleeding disorders. This medicine may significantly reduce platelet, white blood cell, or red blood cell counts, so regular blood monitoring is required during treatment.

Inform your healthcare provider about all medicines you are taking, including prescription drugs, over-the-counter medicines, vitamins, antacids, and herbal supplements. Daslemia is not recommended for children under one year of age.

Common

• Diarrhea
• Nausea, vomiting, tiredness
• Headache
• Cough
• Rash
• Muscle pain, weakness
• Low appetite
• High or low blood pressure

Serious

• Unusual bleeding or bruising
• Fever or signs of infection
• Rapid heart rate
• Heart problems
• Fluid retention
• Breathlessness with swelling of the body
• Changes in consciousness or speech
• Myelosuppression (low blood cell counts)
• Severe allergic reaction

Safety Measures

Alcohol - It is unknown whether it is safe to consume alcohol with Daslemia 50mg Tablet. Please consult your doctor for guidance.
Pregnancy - Daslemia 50mg Tablet is not recommended during pregnancy unless clearly necessary. Your doctor will explain the potential risks if its use is required. Women should use effective contraception during treatment and for at least 30 days after the last dose.
BreastFeeding - Breastfeeding is not recommended while taking Daslemia 50mg Tablet, as it is unknown whether the medicine passes into breast milk. Avoid breastfeeding during treatment and for 2 weeks after your last dose.
Liver - Inform your doctor before starting this treatment if you have liver disease. Your doctor will adjust the dose if necessary.
Kidney - Daslemia 50mg Tablet is likely safe for patients with kidney disease. Limited data suggest that dose adjustment may not be necessary, but please consult your doctor for guidance.


Disclaimer

Med E Hub is committed to delivering reliable, expert-reviewed information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.